Atossa Genetics (ATOS)
3.41
-0.31 -8.33%
NASDAQ
Apr 26, 20:00
Delayed 2m
USD
View All Key Stats
ATOS Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -12.96 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -8.123M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 8.831M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.273 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -1.683M |
| Return on Equity (TTM) | Upgrade |
View All ATOS News
ATOS News
-
WireHeadlineTime (ET)
-
SA Breaking News04/24 12:40
-
SA Breaking News04/24 11:01
-
MT Newswires04/24 09:36
-
SA Breaking News04/24 09:14
-
SA Breaking News04/24 09:13
-
Globe Newswire04/24 08:15
-
Globe Newswire04/23 16:05
-
SA Breaking News04/23 12:45
-
SA Breaking News04/23 11:03
-
MT Newswires04/20 08:44
View All Events
ATOS Events
| Date | Type | Description |
|---|---|---|
| 11/14/2018 | Earnings | Atossa Genetics Inc Third Quarter Earnings Results in 2018 |
| 04/20/2018 | Splits | Ratio: 833333:10000000 |
| 03/08/2018 | Earnings | Atossa Genetics Inc Fourth Quarter Earnings Results in 2017 |
| 11/14/2017 | Earnings | Atossa Genetics Inc Third Quarter Earnings Results in 2017 |
ATOS Fundamentals
Income Statement View Statement
Cash Flow Statement View Statement
ATOS Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ATOS One Page Reports
- One Page Report Download
ATOS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.41 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.atossagenetics.com
- Investor Relations URL: http://ir.atossagenetics.com/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Value
- Next Earnings Release: Nov. 14, 2018
- Last Earnings Release: Mar. 08, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Atossa Genetics Inc mainly focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
ATOS Excel Add-In Codes
- Name: =YCI("ATOS","name")
- Description: =YCI("ATOS","description")
- Sector: =YCI("ATOS","sector")
- Industry: =YCI("ATOS","industry")
- Est. Current Fiscal Year End: =YCI("ATOS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ATOS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ATOS Tweets Stocktwits
Advertisement
